Paper35196993
The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit.
Zuglian G and 6 others. BMC Infect Dis, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit. Papers, record 35196993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35196993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Anti-Bacterial Agents | |
| Bacteria | |
| Drug Resistance, Bacterial | |
| Hospitalization | |
| Humans | |
| Intensive Care Units | |
| Microbial Sensitivity Tests | |
| Pandemics | |
| Retrospective Studies | |
| SARS-CoV-2 |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33339536 | Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study. | Crit Care | 2020 | https://conductscience.org/library/papers/33339536 | PubMed |
| 2 | 33418017 | Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/33418017 | PubMed |
| 3 | 33573070 | Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/33573070 | PubMed |
| 4 | 34652416 | Pressure on the Health-Care System and Intensive Care Utilization During the COVID-19 Outbreak in the Lombardy Region of Italy: A Retrospective Observational Study in 43,538 Hospitalized Patients. | Am J Epidemiol | 2022 | https://conductscience.org/library/papers/34652416 | PubMed |
| 5 | 11337221 | Antibiotic selective pressure and development of bacterial resistance. | Int J Antimicrob Agents | 2001 | https://conductscience.org/library/papers/11337221 | PubMed |
| 6 | 34809698 | The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. | Crit Care | 2021 | https://conductscience.org/library/papers/34809698 | PubMed |
| 7 | 24614243 | Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. | Curr Opin Pulm Med | 2014 | https://conductscience.org/library/papers/24614243 | PubMed |
| 8 | 33546093 | Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/33546093 | PubMed |
| 9 | 32835331 | Low rate of bacterial co-infection in patients with COVID-19. | Lancet Microbe | 2020 | https://conductscience.org/library/papers/32835331 | PubMed |
| 10 | 33681246 | Bergamo and Covid-19: How the Dark Can Turn to Light. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33681246 | PubMed |
| 11 | 32878619 | COVID-19 length of hospital stay: a systematic review and data synthesis. | BMC Med | 2020 | https://conductscience.org/library/papers/32878619 | PubMed |
| 12 | 33666657 | Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/33666657 | PubMed |
| 13 | 33352303 | Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures? | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/33352303 | PubMed |
| 14 | 21793988 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. | Clin Microbiol Infect | 2012 | https://conductscience.org/library/papers/21793988 | PubMed |
| 15 | 31986264 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. | Lancet | 2020 | https://conductscience.org/library/papers/31986264 | PubMed |
| 16 | 15190030 | Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study. | J Antimicrob Chemother | 2004 | https://conductscience.org/library/papers/15190030 | PubMed |
| 17 | 33388794 | Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/33388794 | PubMed |
| 18 | 32567404 | Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. | Expert Rev Respir Med | 2020 | https://conductscience.org/library/papers/32567404 | PubMed |
| 19 | 27865895 | Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. | J Infect | 2017 | https://conductscience.org/library/papers/27865895 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41320199 | COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study. | BMJ Glob Health | 2025 | https://conductscience.org/library/papers/41320199 | PubMed |
| 41045404 | Impact of COVID-19 on the prevalence of multi-drug-resistant bacteria: a literature review and meta-analysis. | Antonie Van Leeuwenhoek | 2025 | https://conductscience.org/library/papers/41045404 | PubMed |
| 40304474 | Changing patterns and biological features of community-acquired Clostridioides difficile infection in Southwest China: 7 years of surveillance data. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40304474 | PubMed |
| 38099348 | Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022. | Euro Surveill | 2023 | https://conductscience.org/library/papers/38099348 | PubMed |
| 37760760 | ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37760760 | PubMed |
| 37508204 | Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37508204 | PubMed |
| 37184033 | Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19). | Infect Control Hosp Epidemiol | 2023 | https://conductscience.org/library/papers/37184033 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35196993
GET https://conductscience.org/api/papers/v1/35196993/authors